Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Molecular targeted therapy in lung cancer.
Naomi Fujioka
, Peter B. Bitterman
Medicine - Hematology, Oncology, Transplant
Pulmonary, Allergy, Critical Care and Sleep Medicine
Carcinogenesis and Chemoprevention
Research output
:
Contribution to journal
›
Letter
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Molecular targeted therapy in lung cancer.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Lung Cancer
100%
Molecular Targeted Therapy
100%
Targeted Therapy
50%
Minnesota
25%
Non-small Cell Lung Cancer (NSCLC)
25%
Genome Sequencing
25%
Genetic mutation
25%
Medicine and Dentistry
Lung Cancer
100%
Molecularly Targeted Therapy
100%
Targeted Therapy
50%
Non Small Cell Lung Cancer
25%
Gene Mutation
25%
Diseases
25%